|Association of IL28B SNP with progression of Egyptian HCV genotype 4 patients to end stage liver disease|
MK El-Awady, L Mostafa, AA Tabll, TH Abdelhafez, NGB El Din, N Zayed, ...
Hepatitis monthly 12 (4), 271, 2012
|A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in mice|
RM Dawood, RI Moustafa, TH Abdelhafez, R El-Shenawy, Y El-Abd, ...
BMC infectious diseases 19 (1), 1-11, 2019
|Three gene signature for predicting the development of hepatocellular carcinoma in chronically infected hepatitis C virus patients|
MK Ibrahim, H Salama, M Abd El Rahman, RM Dawood, NG Bader El Din, ...
Journal of Interferon & Cytokine Research 36 (12), 698-705, 2016
|Impact of OAS1 Exon 7 rs10774671 Genetic Variation on Liver Fibrosis Progression in Egyptian HCV Genotype 4 Patients|
NG Bader El Din, MA Anany, RM Dawood, MK Ibrahim, R El-Shenawy, ...
Viral immunology 28 (9), 509-516, 2015
|Extrahepatic upregulation of transforming growth factor beta 2 in HCV genotype 4-induced liver fibrosis|
M Abd el-Meguid, RM Dawood, MA Mokhles, MK El Awady
Journal of Interferon & Cytokine Research 38 (8), 341-347, 2018
|Expression of reactive oxygen species–related transcripts in Egyptian children with autism|
NA Meguid, SAS Ghozlan, MF Mohamed, MK Ibrahim, RM Dawood, ...
Biomarker insights 12, 1177271917691035, 2017
|Generation of HIV-1 potent and broad neutralizing antibodies by immunization with postfusion HR1/HR2 complex|
R Dawood, F Benjelloun, JJ Pin, A Kone, B Chanut, F Jospin, F Lucht, ...
Aids 27 (5), 717-730, 2013
|Association of myxovirus resistance gene promoter polymorphism with response to combined interferon treatment and progression of liver disease in chronic HCV Egyptian patients|
NG Bader El Din, GM Salum, MA Anany, MK Ibrahim, RM Dawood, ...
Journal of Interferon & Cytokine Research 35 (8), 641-648, 2015
|Secretory IgA specific for MPER can protect from HIV-1 infection in vitro|
F Benjelloun, R Dawood, S Urcuqui-Inchima, B Chanut, B Verrier, F Lucht, ...
Aids 27 (12), 1992-1995, 2013
|Tumor necrosis factor-α-G308A polymorphism is associated with liver pathological changes in hepatitis C virus patients|
NGB El Din, S Farouk, R El-Shenawy, MK Ibrahim, RM Dawood, ...
World journal of gastroenterology 22 (34), 7767, 2016
|Vascular endothelial growth factor expression in hepatitis C virus-induced liver fibrosis: a potential biomarker|
GM Salum, NG Bader El Din, MK Ibrahim, MA Anany, RM Dawood, ...
Journal of Interferon & Cytokine Research 37 (7), 310-316, 2017
|Transcriptional dysregulation of upstream signaling of IFN pathway in chronic HCV type 4 induced liver fibrosis|
MK Ibrahim, GM Salum, NG Bader El Din, RM Dawood, A Barakat, ...
PloS one 11 (5), e0154512, 2016
|Dysregulation of fibrosis related genes in HCV induced liver disease|
RM Dawood, M Abd el-Meguid, MK Ibrahim, NGB El Din, A Barakat, ...
Gene 664, 58-69, 2018
|Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients|
GM Salum, RM Dawood, M Abd el-Meguid, NE Ibrahim, AOA Aziz, ...
Genes & Diseases 7 (3), 392-400, 2020
|Hepatitis C virus serologic relapse after treatment with direct-acting antivirals is dependent on viral RNA levels in peripheral blood mononuclear cells and the grade of liver …|
MDA Abd Alla, MK El Awady, RM Dawood, MA Elhawary, SS Al-Azhari, ...
Archives of virology 163 (10), 2765-2774, 2018
|Immunogenicity and safety of HCV E1E2 peptide vaccine in chronically HCV-infected patients who did not respond to interferon based therapy|
MK El-Awady, M El Gendy, I Waked, AA Tabll, Y El Abd, N Bader El Din, ...
Vaccine 10, 2013
|Mice antibody response to conserved nonadjuvanted multiple antigenic peptides derived from E1/E2 regions of hepatitis C virus|
TH Abdelhafez, NG Bader El Din, AA Tabll, MM Mashaly, RM Dawood, ...
Viral immunology 30 (5), 359-365, 2017
|Polymorphism in variable number of tandem repeats of dopamine D4 gene is a genetic risk factor in attention deficit hyperactive egyptian children: pilot study|
O Shahin, NA Meguid, O Raafat, RM Dawood, M Doss, NGBE Din, ...
Biomarker insights 10, BMI. S18519, 2015
|A study of CC-Chemokine Receptor 5 (CCR5) polymorphism on the outcome of HCV therapy in Egyptian patients|
MH Omran, M Khamis, N Nasr, AA Massoud, SS Youssef, NGB El Din, ...
Hepatitis monthly 13 (12), 2013
|Key Players of Hepatic Fibrosis|
RM Dawood, MA El-Meguid, GM Salum, MK El Awady
Journal of Interferon & Cytokine Research 40 (10), 472-489, 2020